Measles Virus IgG
Description:
Qualititative chemiluminescent immuno-assay (CLIA) for Measles virus IgG antibody testing. Used to determine measles susceptibility in pregnant women and immunocompromised individuals following possible measles exposure, or to assess need for MMR vaccine in health care workers and other vaccine candidates. This assay is available routinely Mon to Fri.
This test is not UKAS accredited
This test is not UKAS accredited
Clinical details:
- Post possible measles exposure to assess susceptibility and need for post-exposure prophylaxis. For individiuals at risk of severe measles - pregnant; immunocompromised - and without a reliable history of vaccination.
- Assess need for MMR vaccine in health care workers and other vaccine candidates.
- Assess need for MMR vaccine in health care workers and other vaccine candidates.
Reference range:
Not applicable
Synonyms or keywords:
Measles
Pregnancy
Immunocompromised host
MMR
health care workers
Units:
Qualitative - Detected/Not Detected
Department:
Location:
Sample type and Volume required:
2.5 – 5ml Yellow Top Serum Separation Tube (SST) Clotted Blood (for serum).
Turnaround time:
7 days
Storage and transport:
Place labelled sample in a sealed sample bag and send to Central Specimen Reception (CSR). To prevent sample haemolysis please store samples in refrigerator if a delay in sending samples to CSR is unavoidable.
Contacts:
For clinical advice or interpretation of results, please contact the laboratory in the first instance.
Laboratory:
Last updated: 18/12/2024
